⌘K
Loading ticker…
As of 2026-08-24, Xencor, Inc. (XNCR) has a 3-month relative strength percentile of 99 and a leadership percentile of 99 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 91. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.5%, relative volume 0.90×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
XNCR is held by 28 ETFs as of May 2026. Top owner: VTWO at 0.02% weight, $4M notional. Top 3 carry $11M.
Held by 74 ETFs · $218M across latest filings · largest weight 0.56% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.02% | $4M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $4M | — |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.05% | $3M | — |
| AVSC | 0.07% | $2M | −0.01 pp |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.10% | $2M |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| −0.02 pp |
| VHTVanguard Health Care ETF | 0.01% | $2M | — |
| SBIO | 0.56% | $898K | −0.03 pp |
| VTWV | 0.05% | $669K | — |
| PSCH | 0.45% | $594K | −0.09 pp |
| ISMD | 0.17% | $528K | +0.01 pp |
Showing 10 of 28 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XNCR Jan avg: -6.74% median: -16.18% win: 25% σ: 22.50% n: 4 2022-04-12 → 2026-07-31 | XNCR Feb avg: 2.50% median: 1.61% win: 50% σ: 16.17% n: 4 2022-04-12 → 2026-07-31 | XNCR Mar avg: -13.26% median: -9.38% win: 0% σ: 12.36% n: 4 2022-04-12 → 2026-07-31 | XNCR Apr avg: -2.82% median: -5.20% win: 20% σ: 4.07% n: 5 2022-04-12 → 2026-07-31 | XNCR May avg: -4.49% median: -0.42% win: 40% σ: 15.41% n: 5 2022-04-12 → 2026-07-31 | XNCR Jun avg: 5.63% median: -1.75% win: 40% σ: 22.86% n: 5 2022-04-12 → 2026-07-31 | XNCR Jul avg: 8.27% median: 5.85% win: 80% σ: 10.45% n: 5 2022-04-12 → 2026-07-31 | XNCR Aug avg: -8.54% median: -8.76% win: 0% σ: 4.97% n: 4 2022-04-12 → 2026-07-31 (current) | XNCR Sep avg: 12.35% median: 6.71% win: 50% σ: 23.43% n: 4 2022-04-12 → 2026-07-31 | XNCR Oct avg: 5.94% median: 6.13% win: 75% σ: 16.10% n: 4 2022-04-12 → 2026-07-31 | XNCR Nov avg: 12.86% median: 11.94% win: 100% σ: 8.18% n: 4 2022-04-12 → 2026-07-31 | XNCR Dec avg: -4.62% median: -10.92% win: 25% σ: 13.61% n: 4 2022-04-12 → 2026-07-31 |